These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. The in vivo mitochondrial two-step maturation of human frataxin. Schmucker S; Argentini M; Carelle-Calmels N; Martelli A; Puccio H Hum Mol Genet; 2008 Nov; 17(22):3521-31. PubMed ID: 18725397 [TBL] [Abstract][Full Text] [Related]
30. The Friedreich's ataxia protein frataxin modulates DNA base excision repair in prokaryotes and mammals. Thierbach R; Drewes G; Fusser M; Voigt A; Kuhlow D; Blume U; Schulz TJ; Reiche C; Glatt H; Epe B; Steinberg P; Ristow M Biochem J; 2010 Nov; 432(1):165-72. PubMed ID: 20819074 [TBL] [Abstract][Full Text] [Related]
31. Friedreich's ataxia reveals a mechanism for coordinate regulation of oxidative metabolism via feedback inhibition of the SIRT3 deacetylase. Wagner GR; Pride PM; Babbey CM; Payne RM Hum Mol Genet; 2012 Jun; 21(12):2688-97. PubMed ID: 22394676 [TBL] [Abstract][Full Text] [Related]
32. Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia. Perdomini M; Belbellaa B; Monassier L; Reutenauer L; Messaddeq N; Cartier N; Crystal RG; Aubourg P; Puccio H Nat Med; 2014 May; 20(5):542-7. PubMed ID: 24705334 [TBL] [Abstract][Full Text] [Related]
33. Lipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia. Khdour OM; Bandyopadhyay I; Chowdhury SR; Visavadiya NP; Hecht SM Bioorg Med Chem; 2018 Jul; 26(12):3359-3369. PubMed ID: 29773347 [TBL] [Abstract][Full Text] [Related]
34. The role of oxidative stress in Friedreich's ataxia. Lupoli F; Vannocci T; Longo G; Niccolai N; Pastore A FEBS Lett; 2018 Mar; 592(5):718-727. PubMed ID: 29197070 [TBL] [Abstract][Full Text] [Related]
35. Mesenchymal Stem Cell-Derived Factors Restore Function to Human Frataxin-Deficient Cells. Kemp K; Dey R; Cook A; Scolding N; Wilkins A Cerebellum; 2017 Aug; 16(4):840-851. PubMed ID: 28456899 [TBL] [Abstract][Full Text] [Related]
36. Frataxin deficiency leads to defects in expression of antioxidants and Nrf2 expression in dorsal root ganglia of the Friedreich's ataxia YG8R mouse model. Shan Y; Schoenfeld RA; Hayashi G; Napoli E; Akiyama T; Iodi Carstens M; Carstens EE; Pook MA; Cortopassi GA Antioxid Redox Signal; 2013 Nov; 19(13):1481-93. PubMed ID: 23350650 [TBL] [Abstract][Full Text] [Related]
37. Characterization of a new N-terminally acetylated extra-mitochondrial isoform of frataxin in human erythrocytes. Guo L; Wang Q; Weng L; Hauser LA; Strawser CJ; Mesaros C; Lynch DR; Blair IA Sci Rep; 2018 Nov; 8(1):17043. PubMed ID: 30451920 [TBL] [Abstract][Full Text] [Related]
38. A multiple animal and cellular models approach to study frataxin deficiency in Friedreich Ataxia. Mosbach V; Puccio H Biochim Biophys Acta Mol Cell Res; 2024 Oct; 1871(7):119809. PubMed ID: 39134123 [TBL] [Abstract][Full Text] [Related]
39. Adding a temporal dimension to the study of Friedreich's ataxia: the effect of frataxin overexpression in a human cell model. Vannocci T; Notario Manzano R; Beccalli O; Bettegazzi B; Grohovaz F; Cinque G; de Riso A; Quaroni L; Codazzi F; Pastore A Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29794127 [TBL] [Abstract][Full Text] [Related]
40. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia. Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]